UK healthtech startup Stride raises £4.6M to expand preventative health platform

What happened

UK-basedpreventative health startup Stride has raised £4.6 million in seed funding tofurther develop its diagnostics-driven health platform and supportinternational expansion. UK-based preventative health startup Stride has raised £4.6 million in seed funding to further develop its diagnostics-driven health platform and support international expansion.

Launched in May 2024 by Andrew Steele , an Olympic medallist and co-founder of DNAfit, Stride offers a preventative health membership that combines DNA, blood and gut health testing with personalised insights. The round contains investment from Arāya Ventures, Morgan Stanley Inclusive & Sustainable Ventures, Better Ventures, Innovate UK and an a16z Scout Fund investor, alongside a group of angel investors. The platform aims to help individuals better understand their health data, track changes over time and make more informed decisions about their health and wellbeing.

Key facts

• The round — includes: investment from Arāya Ventures, Morgan Stanley Inclusive & Sustainable Ventures, Better Ventures, Innovate UK and an a16z Scout Fund investor, alongside a group of angel investors